Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In the United States, the financial impact of medications like Tirzepatide can vary widely based on insurance coverage and availability of financial assistance programs
Outcomes remain highly uncertain and hinge on uptake, effectiveness, persistency, and any benefits beyond BMI reduction so insurers should monitor this fast-moving landscape and consider implications for trend assumptions, lapse/anti-selection risk, underwriting, and claims
Needless to say, its complicated
As of 2025, polling suggests that one in eight adults in the United States is taking GLP-1 medications, and figures are likely to increase even further in the coming years
US$ 24.18
US$ 24.51
US$ 28.05
US$ 20.87
